Kelso Pharma acquires UK pharma business, ALTURiX
Kelso Pharma, the growing specialty pharma business backed by Apposite Capital, the healthcare specialist private equity investor, today (19 February 2025) announces the acquisition of the UK pharma business, ALTURiX Holdings Limited (ALTURiX). The transaction marks a significant step towards Kelso’s vision of building a specialty pharma business of scale in the UK and ultimately […]
